Holen Sie sich die Stockscreener-App
0.2573
6.99%
0.0168
Schlusskurs vom Vortag:
$0.2405
Offen:
$0.2374
24-Stunden-Volumen:
4.58M
Relative Volume:
0.27
Marktkapitalisierung:
$3.06M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.53M
KGV:
-0.0534
EPS:
-4.82
Netto-Cashflow:
$-11.12M
1W Leistung:
+21.25%
1M Leistung:
-11.00%
6M Leistung:
-62.27%
1J Leistung:
-84.41%
1-Tages-Spanne:
$0.2351
$0.2614
1-Wochen-Bereich:
$0.2071
$0.2689
52-Wochen-Spanne:
$0.15
$3.10
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Firmenname
Processa Pharmaceuticals Inc
Sektor
Branche
Telefon
443-776-3133
Adresse
7380 COCA COLA DRIVE, HANOVER
Vergleichen Sie PCSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
0.2573 | 6.54M | 0 | -11.53M | -11.12M | -4.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.19 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.37 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.26 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
588.61 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.06 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-25 | Eingeleitet | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten
What drives Processa Pharmaceuticals Inc. stock priceDynamic profit opportunities - Autocar Professional
What analysts say about Processa Pharmaceuticals Inc. stockExceptional profit potential - Autocar Professional
Processa Pharmaceuticals Inc. Stock Analysis and ForecastRecord-breaking capital gains - jammulinksnews.com
Processa Pharmaceuticals Inc (PCSA) Stock: A Year of Stock Market Dynamics - investchronicle.com
What makes Processa Pharmaceuticals Inc. stock price move sharplyFree Wealth-Building Investment Strategies - Newser
Is Processa Pharmaceuticals Inc. a good long term investmentRecord-breaking gains - Autocar Professional
Processa Pharmaceuticals Approves Key Proposals at Annual Meeting - The Globe and Mail
RedChip Showcases Processa Pharmaceuticals and BullFrog AI on Bloomberg TV - AInvest
Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Des Moines Register
The Convergence of AI and Biotech: BullFrog AI and Processa Pharmaceuticals as Catalysts for Disruption - AInvest
How Processa Pharmaceuticals Inc. stock performs during market volatilityTrend Following Trades - Newser
Why Processa Pharmaceuticals Inc. stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser
Processa Pharmaceuticals Reschedules Annual Shareholder Meeting - TipRanks
Processa Pharmaceuticals to reconvene annual meeting after achieving quorum By Investing.com - Investing.com South Africa
Processa Pharmaceuticals to reconvene annual meeting after achieving quorum - Investing.com
Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress - MSN
Processa Pharmaceuticals: Betting on Catalyst-Driven Value Acceleration - AInvest
Processa Stock Soars 33.96% on Penny Stock Inclusion - AInvest
Processa Stock Soars 14.62% on Penny Stock Inclusion - AInvest
12 Best Fundamentally Strong Penny Stocks to Invest in - Insider Monkey
Processa Pharmaceuticals stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com UK
Processa terminates license agreement for PCS3117 - TipRanks
Processa Pharmaceuticals adjourns annual meeting due to lack of quorum By Investing.com - Investing.com UK
Processa Pharmaceuticals adjourns annual meeting due to lack of quorum - Investing.com
Processa Pharmaceuticals Adjourns Annual Shareholder Meeting - TipRanks
Processa Pharmaceuticals Plunges 15.31% Amid Market Volatility - AInvest
Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more - Medical Marketing and Media
Processa Pharmaceuticals Announces Public Offering Pricing - TipRanks
Processa inks licensing deal with Intact for gastroparesis drug By Investing.com - Investing.com India
Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Processa Pharmaceuticals Inc-Aktie (PCSA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ng George K | Chief Executive Officer |
Jan 27 '25 |
Buy |
0.80 |
87,200 |
69,542 |
87,200 |
| Young David | Pres. Research & Development |
Jan 27 '25 |
Buy |
0.80 |
124,500 |
99,289 |
205,405 |
| Lin Patrick | Chief Business - Strategy Off |
Jan 27 '25 |
Buy |
0.80 |
43,500 |
34,691 |
43,500 |
3.28%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):